Professor Marco Falasca.

Congratulations to Curtin Health Innovation Research Institute (CHIRI) researcher Professor Marco Falasca on the publishing of his latest research paper on the role cannabinoid plays in the survival rates of mice with pancreatic cancer.

The research, led by Professor Falasca and Queen Mary University of London, found mice with pancreatic cancer survived almost three times longer than normal if they were treated with a naturally occurring cannabinoid as well as a popular chemotherapy medication. Given the mice form of the cancer closely resembles the human disease, the findings may be significant for the treatment of pancreatic cancer in humans.

The paper ‘GPR55 Signalling Promotes Proliferation of Pancreatic Cancer Cells and Tumour Growth in Mice, and its Inhibition Increases Effects of Gemcitabine’ was published in the journal Oncogene.

You can read more about the research at: https://buff.ly/2AsSXvi